Synapse - Matthew Lubin

Matthew Lubin

Research Focus

Former Employee. MOLECULAR PHARMACOLOGY PROGRAM; NE Agency Contingent

Recent additions – View all

CTLA-4 blockade drives loss of T(reg) stability in glycolysis-low tumours
Journal Article

Zappasodi, R.; Serganova, I.; Cohen, I. J.; Maeda, M.; Shindo, M.; Senbabaoglu, Y.; Watson, M. J.; Leftin, A.; Maniyar, R.; Verma, S.; more...
Nature (2021)

Fulltext@MSK | Save
CTLA-4 blockade promotes Treg glucose metabolism and reduces Treg functional stability in glycolysis-defective tumors
Meeting Abstract

Zappasodi, R.; Serganova, I.; Cohen, I.; Maeda, M.; Senbabaoglu, Y.; Shindo, M.; Maniyar, R.; Mane, M.; Leftin, A.; Watson, M.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save
CTLA-4 blockade drives loss of regulatory T cell functional stability in glycolysis defective tumors
Meeting Abstract

Zappasodi, R.; Serganova, I.; Cohen, I.; Maeda, M.; Shindo, M.; Senbabaoglu, Y.; Leftin, A.; Maniyar, R.; Verma, S.; Lubin, M.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Co-authors at MSK

3

Ackerstaff
3

Blasberg
3

Cohen
3

Ghosh
3

Koutcher
3

Ko
3

Leftin
3

Maeda
3

Mane
3

Maniyar
3

Merghoub
3

Senbaba...
3

Serganova
3

Shindo
3

Verma
3

Wolchok
3

Zappasodi
2

Abu-Akeel
1

Liu
1

Zhong

Types of Work

Publications